COVID-19 as a STING disorder with delayed over-secretion of interferon-beta

COVID-19 as a STING disorder with delayed over-secretion of interferon-beta

Bibliographic Details
Main Authors:	Jean-Marie Berthelot, Frédéric Lioté
Format:	Article
Language:	English
Published:	Elsevier 2020-06-01
Series:	EBioMedicine
Online Access:	http://www.sciencedirect.com/science/article/pii/S2352396420301766

Similar Items

Lymphocyte Changes in Severe COVID-19: Delayed Over-Activation of STING?
by: Jean-Marie Berthelot, et al.
Published: (2020-12-01)

Food insecurity will be the sting in the tail of COVID-19
by: The Lancet Global Health
Published: (2020-06-01)

Interferon beta-1a for COVID-19: critical importance of the administration route
by: Juho Jalkanen, et al.
Published: (2020-06-01)

Interferon- and STING-independent induction of type I interferon stimulated genes during fractionated irradiation
by: Ruben S. A. Goedegebuure, et al.
Published: (2021-05-01)

The administration of interferon-beta1b and favipiravir in patients with COVID-19 pneumonia
by: Mehrdad Hasibi, et al.
Published: (2021-06-01)

Reactive oxygen species oxidize STING and suppress interferon production
by: Lili Tao, et al.
Published: (2020-09-01)

Photochemotherapy Induces Interferon Type III Expression via STING Pathway
by: Edyta Biskup, et al.
Published: (2020-11-01)

Interferon-independent STING signaling promotes resistance to HSV-1 in vivo
by: Lívia H. Yamashiro, et al.
Published: (2020-07-01)

SV40 Large T Antigen Is Not Responsible for the Loss of STING in 293T Cells but Can Inhibit cGAS-STING Interferon Induction
by: Joshua B. Reus, et al.
Published: (2020-01-01)

Computational study on new natural compound agonists of stimulator of interferon genes (STING).
by: Sheng Zhong, et al.
Published: (2019-01-01)

Molecular Mechanisms of the Toll-Like Receptor, STING, MAVS, Inflammasome, and Interferon Pathways
by: Nathan P. Manes, et al.
Published: (2021-06-01)

Successful treatment of plasmapheresis followed by interferon beta-1a in a child with severe COVID-19
by: Rana Saleh, et al.
Published: (2021-01-01)

The Impact of Interferon Beta-1b Therapy on Thyroid Function and Autoimmunity Among COVID-19 Survivors
by: David Tak Wai Lui, et al.
Published: (2021-09-01)

Mutant p53 attenuates the anti-tumorigenic activity of fibroblasts-secreted interferon beta.
by: Shalom Madar, et al.
Published: (2013-01-01)

Secreted expression of an active human interferon‐beta (HuIFNβ) in Kluyveromyces lactis
by: Aravind Madhavan, et al.
Published: (2016-05-01)

Both STING and MAVS fish orthologs contribute to the induction of interferon mediated by RIG-I.
by: Stéphane Biacchesi, et al.
Published: (2012-01-01)

STING-Mediated IFI16 Degradation Negatively Controls Type I Interferon Production
by: Dapei Li, et al.
Published: (2019-10-01)

The value of interferon therapy for COVID-19 in children
by: L. N. Mazankova, et al.
Published: (2021-04-01)

Type I Interferons in COVID-19 Pathogenesis
by: Enrico Palermo, et al.
Published: (2021-08-01)

Interferon beta-1a as a Candidate for COVID-19 Treatment; An Open-Label Single-Arm Clinical Trial
by: Pooya Payandemehr, et al.
Published: (2020-05-01)

Cutibacterium acnes Infection Induces Type I Interferon Synthesis Through the cGAS-STING Pathway
by: Katrin Fischer, et al.
Published: (2020-10-01)

Delivery of Stimulator of Interferon Genes (STING) Agonist Using Polypeptide‐Modified Dendrimer Nanoparticles in the Treatment of Melanoma
by: Dosta, Pere, et al.
Published: (2022)

Beta-interferons in multiple sclerosis
by: Aggarwal Sourabh, et al.
Published: (2010-01-01)

Acute Ischemic Stroke Due to Multiple Bee Stings_A Delayed Complication
by: Arunmozhimaran Elavarasi, et al.
Published: (2020-01-01)

Effectiveness of Interferon Beta 1a, compared to Interferon Beta 1b and the usual therapeutic regimen to treat adults with moderate to severe COVID-19: structured summary of a study protocol for a randomized controlled trial
by: Seyed Sina Naghibi Irvani, et al.
Published: (2020-06-01)

Modern opportunities of interferons in treatment of children with COVID-19
by: Asiya I. Safina, et al.
Published: (2021-03-01)

The double edged interferon riddle in COVID-19 pathogenesis
by: Rahul Gupta
Published: (2020-11-01)

Interferon-α2b Treatment for COVID-19
by: Qiong Zhou, et al.
Published: (2020-05-01)

Dysregulated Interferon Response Underlying Severe COVID-19
by: LeAnn Lopez, et al.
Published: (2020-12-01)

Interferon-β: treatment option against COVID-19
by: Faiz Ul haq, et al.
Published: (2020-07-01)

The dual sides of interferon induction in COVID-19 treatment
by: Sadra Nadimi Parashkouhi, et al.
Published: (2021-03-01)

An efficient protocol for avoid sequelae over stingray sting injury
by: Raphael Sanzio PIMENTA, et al.
Published: (2017-08-01)

Structure and function studies of human STING and mouse STING
by: Cheng-Kang Chen, et al.
Published: (2013)

STAG2 deficiency induces interferon responses via cGAS-STING pathway and restricts virus infection
by: Siyuan Ding, et al.
Published: (2018-04-01)

Chikungunya virus antagonizes cGAS-STING mediated type-I interferon responses by degrading cGAS.
by: L G Webb, et al.
Published: (2020-10-01)

STING-mediated type-I interferons contribute to the neuroinflammatory process and detrimental effects following traumatic brain injury
by: Amar Abdullah, et al.
Published: (2018-11-01)

Priming of the cGAS-STING-TBK1 Pathway Enhances LPS-Induced Release of Type I Interferons
by: Alessandra Tesser, et al.
Published: (2021-04-01)

Stinging Nettle
by: Caverhill, Cassandra M.
Published: (2021)

Scorpion Sting
by: Suchita Khadse
Published: (2016-01-01)

Sting to the heart – Acute pulmonary edema following hymenoptera sting
by: Jijin Satheesh, et al.
Published: (2018-01-01)